See the highest-grossing horror movies in history
Horror movies keep proving they can out-earn expectations even when studios bet small or swing big. Right now the conversation circles back to the all-time earners because two 2025 releases and one micro-budget 2026 surprise have rearranged the unadjusted worldwide chart. Tracking the leaders shows how budgets, franchises, and original stories each carve out their slice of the market.
Top earner still holds
It opened in 2017 and immediately reset the ceiling for R-rated horror. The Stephen King adaptation finished near $702 million worldwide on a budget under $40 million. That figure still tops every later release in unadjusted dollars.
The film’s domestic run topped $328 million and set an opening-weekend record for the genre at the time. Marketing leaned into the clown imagery that later flooded social feeds. The result was a cultural shorthand that keeps the title in every new ranking.
Its staying power also lifted the profile of the sequel two years later. Studios noticed that a single well-reviewed horror title could drive repeat business across an entire Labor Day frame.
Twist ending built the second spot
The Sixth Sense arrived in 1999 and collected roughly $673 million worldwide. Domestic earnings reached $294 million, helped by word-of-mouth that turned the twist into a repeat-viewing hook.
M. Night Shyamalan’s early success showed studios that supernatural stories could play in multiplexes outside the usual Halloween corridor. The film’s rewatch value kept it circulating in pop-culture lists long after its initial run.
That late-90s breakthrough set a template later entries still follow. Audiences learned to expect one reveal that reframes everything, and marketers learned to protect the secret until opening weekend.
Star power widened the lane
I Am Legend used Will Smith’s draw to push horror-action into mainstream theaters. The 2007 release grossed about $585 million worldwide and proved a lone-hero premise could travel overseas.
Its post-apocalyptic New York setting gave visual scale that appealed beyond core genre fans. The film’s marketing campaign treated the infected creatures as set pieces rather than simple jump scares.
That blend of star vehicle and horror trappings broadened the audience pool. Later tentpoles would copy the formula when they needed to hedge against narrower horror demographics.
Summer benchmark still counts
Jaws established the modern blockbuster calendar in 1975. Its unadjusted worldwide total sits near $495 million, a figure that looks modest only until inflation and re-release context are added.
The film turned a Massachusetts beach town into a tourist brand and gave studios the template for wide summer releases. Its three-day opening numbers rewrote distribution playbooks that still operate today.
References to the shark keep surfacing whenever a new water-set thriller arrives. The movie’s longevity shows that a single well-crafted horror title can generate decades of ancillary revenue.
Franchise durability in 2025
The Conjuring: Last Rites extended a long-running series into the current chart. The 2025 entry reached roughly $499 million worldwide, landing it inside the global top tier despite modest reviews.
Producers relied on the Warren name recognition and a built-in audience that returns for each new case. Marketing kept the campaign focused on practical scares rather than expensive VFX.
The result reinforced that established universes can still deliver predictable earnings even when original concepts dominate headlines. Studios continue to green-light additional chapters while the brand remains bankable.
Original story breaks through
Sinners arrived in 2025 as Ryan Coogler’s first horror feature and collected about $370 million worldwide. Domestic numbers approached $280 million, an unusually strong split for a non-franchise title.
The vampire premise drew audiences looking for something outside the usual Conjuring or Insidious cycle. Social chatter praised the period setting and the lead performances, driving second-week holds.
Its success prompted other producers to revisit original scripts that had sat on shelves during the franchise-heavy stretch. The takeaway was that star directors plus fresh concepts could still open wide.
Micro-budget outlier arrives
Obsession reached theaters in 2026 on a budget reportedly below $15 million. Early tracking placed it among the year’s stronger domestic horror performers, cracking several top-10 lists for the category.
Focus Features and Blumhouse handled the release, betting that a cursed-toy premise could generate word-of-mouth without large ad spends. Social clips of the practical effects helped the film trend on short-form platforms.
The project’s performance underscored that low-cost entries can still post meaningful profit when marketing aligns with niche online communities. Studios now watch similar titles for signs of breakout potential.
2024 set the recent stage
Longlegs earned roughly $128 million worldwide on a sub-$10 million budget, becoming Neon’s highest-grossing release. Its occult-serial-killer angle benefited from a tightly controlled marketing rollout that kept the villain’s face hidden until release.
Smile 2 followed weeks later and crossed $138 million globally. The sequel leaned on the curse motif that had already proven popular in the first film’s run.
Together the two titles demonstrated that 2024’s R-rated horror slate could deliver solid returns without superhero-level budgets. That momentum carried into the 2025 slate and shaped release-date strategies for 2026.
Profit patterns keep shifting
High earners now arrive from both franchise extensions and one-off originals. The common thread is controlled spending paired with targeted social campaigns that reach core horror fans first.
Studios track pre-sales and social sentiment more closely than ever because horror remains one of the few genres that can open wide on a modest spend. When those indicators line up, even micro-budget titles can climb the all-time lists.
The chart therefore reflects both legacy blockbusters and recent surprises. Future releases will be measured against this mixed field rather than any single dominant era.
What the numbers signal next
The current spread of earners shows horror movies can succeed across budget tiers when the concept and release timing align. Producers are already weighing 2027 slates that mix legacy sequels with new original scripts tested in limited markets first. The takeaway is that theatrical horror retains elasticity as long as audiences keep showing up for both the familiar and the unexpected.
